This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.

Featured Stock in November’s Dividend Growth Model Portfolio

New Constructs

New Constructs
Visit: New Constructs


Investment Analyst

Nine new stocks make our Dividend Growth Stocks Model Portfolio this month, which was made available to members on November 26, 2019.

Recap from October’s Picks

Our Dividend Growth Stocks Model Portfolio underperformed the S&P 500 from October 30, 2019 through November 22, 2019. The Model Portfolio rose 1.7% on a price return basis and 1.8% on a total return basis. The S&P 500 rose 2.2% on a price return and total return basis. The portfolio’s best performing stock was up 24%. Overall, 13 out of the 30 Dividend Growth Stocks outperformed the S&P from October 30, 2019 through November 22, 2019, and 20 had positive returns.

Only our research utilizes the superior data and earnings adjustments featured by the HBS & MIT Sloan paper, “Core Earnings: New Data and Evidence.” The long-term success of our model portfolio strategies highlights the value of our Robo-Analyst technology[1], which scales our forensic accounting expertise (featured in Barron’s) across thousands of stocks[2].

The methodology for this model portfolio mimics an All-Cap Blend style with a focus on dividend growth. Selected stocks earn an Attractive or Very Attractive rating, generate positive free cash flow (FCF) and economic earnings, offer a current dividend yield >1%, and have a 5+ year track record of consecutive dividend growth. This model portfolio is designed for investors who are more focused on long-term capital appreciation than current income, but still appreciate the power of dividends, especially growing dividends.

Featured Stock from November: JPMorgan Chase & Company (JPM: $131/share)

JPMorgan Chase & Company (JPM) is the featured stock from November’s Dividend Growth Stocks Model Portfolio.

Since 2010, JPM has grown revenue by 2% compounded annually and after-tax profit (NOPAT) by 8% compounded annually. The company earned $34.2 billion in NOPAT over the trailing twelve months, which is up 15% over the prior TTM period. JPM’s NOPAT margin is up from 15% in 2010 to 24% TTM while its return on invested capital (ROIC) improved from 7% to 11% over the same time.

Figure 1: JPM’s Revenue & NOPAT Since 2010

JPM’s Revenue & NOPAT Since 2010

Sources: New Constructs, LLC and company filings

Steady Dividend Growth Supported by FCF

JPM has increased its annual dividend each of the past nine years. The company increased its annualized dividend from $1.58/share in 2014 to $2.72/share in 2018, a 14% compound annual growth rate. Its current quarterly dividend, $0.90/share, equates to $3.60/share annually. Most importantly, JPM easily generates the cash flow needed to continue paying and growing its dividend. Over the past five years, JPM has generated a cumulative $76.9 billion in FCF (19% of market cap) while paying $42.4 billion in dividends.

Companies with FCF well in excess of dividend payments provide higher quality dividend growth opportunities because we know the firm generates the cash to support a higher dividend. On the other hand, the dividend of a company where FCF falls short of the dividend payment over time cannot be trusted to grow or even maintain its dividend because of inadequate free cash flow.

Figure 2: Free Cash Flow (FCF) vs. Regular Dividend Payments

 Free Cash Flow (FCF) vs. Regular Dividend Payments

Sources: New Constructs, LLC and company filings

JPM Is Undervalued

At its current price of $131/share, JPM has a price-to-economic book value (PEBV) ratio of 0.9. This ratio means the market expects JPM’s NOPAT to permanently decline by 10%. This expectation seems rather pessimistic for a firm that has grown NOPAT by 8% compounded annually since 2010 and 11% compounded annually over the past two decades.

If JPM can maintain TTM (24%) and grow NOPAT by just 3% compounded annually for the next decade, the stock is worth $158/share today – a 21% upside. See the math behind this reverse DCF scenario. Add in JPM’s 2.7% dividend yield and history of dividend growth, and it’s clear why this stock is in November’s Dividend Growth Stocks Model Portfolio.

Critical Details Found in Financial Filings by Our Robo-Analyst Technology

As investors focus more on fundamental research, research automation technology is needed to analyze all the critical financial details in financial filings as shown in the Harvard Business School and MIT Sloan paper, “Core Earnings: New Data and Evidence”.

Below are specifics on the adjustments we make based on Robo-Analyst findings in JPMorgan Chase & Company’s 2018 10-K:

Income Statement: we made $6 billion of adjustments with a net effect of removing $218 million in non-operating expense (<1% of revenue). See all adjustments made to JPM’s income statement here.

Balance Sheet: we made $56.4 billion of adjustments to calculate invested capital with a net increase of $38.9 billion. The most notable adjustment was $16.1 billion (6% of reported net assets) related to goodwill. See all adjustments to JPM’s balance sheet here.

Valuation: we made $48 billion of adjustments with a net effect of decreasing shareholder value by $38.9 billion. The largest adjustment to shareholder value was $28.4 billion in preferred stock. This adjustment represents 7% of JPM’s market value. See all adjustments to JPM’s valuation here.

[1] Harvard Business School features the powerful impact of our research automation technology in the caseNew Constructs: Disrupting Fundamental Analysis with Robo-Analysts.

[2] This paper compares our analytics on a mega cap company to other major providers. The Appendix details exactly how we stack up.

This article originally published on December 5, 2019.

Follow us on TwitterFacebookLinkedIn, and StockTwits for real-time alerts on all our research.

Click here to download a PDF of this report.

Disclosure: New Constructs

Disclosure: David Trainer, Kyle Guske II, Sam McBride, Andrew Gallagher, and Matt Shuler receive no compensation to write about any specific stock, style, or theme.

About New Constructs

Our stock rating methodology instantly informs you of the quality of the business and the fairness of the stock’s valuation. We do the diligence on earnings quality and valuation so you don’t have to.

In-depth risk/reward analysis underpins our stock rating. Our stock rating methodology grades every stock according to what we believe are the 5 most important criteria for assessing the quality of a stock. Each grade reflects the balance of potential risk and reward of buying that stock. Our analysis results in the 5 ratings described below. Very Attractive and Attractive correspond to a “Buy” rating, Very Unattractive and Unattractive correspond to a “Sell” rating, while Neutral corresponds to a “Hold” rating.

Disclosure: Interactive Brokers

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from New Constructs and is being posted with permission from New Constructs. The views expressed in this material are solely those of the author and/or New Constructs and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

trading top